Precipio inc.

NEW HAVEN, Conn., June 14, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. leveraged its proprietary HemeScreen Cytopenia panel as part of the diagnostic process for ...

Precipio inc. Things To Know About Precipio inc.

Stock analysis for Precipio Inc (PRPO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Except as otherwise indicated in the table below, addresses of named beneficial owners are in care of Precipio, Inc., 4 Science Park, New Haven, CT 06511. Beneficial ownership information of persons other than our current executive officers and directors is based on available information including, but not limited to, Schedules 13D, 13F or 13G ...The average Web Designer I salary in the United States is $67,135 as of October 25, 2023, but the range typically falls between $59,939 and $74,962. Salary ranges can vary widely depending on many important factors, including education, certifications, additional skills, the number of years you have spent in your profession.Find the latest Precipio, Inc. (PRPO) stock quote, history, news and other vital information to help you with your stock trading and investing.26 Aug 2021 ... New Haven, CT, and Fort Myers, FL, August 26, 2021 – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), and American ...

Nov 29, 2023 · Precipio, Inc. (PRPO) Q2 2023 Earnings Call Transcript. Seeking Alpha - Aug 17, 2023, 6:32PM. Precipio launches quantitative BCR-ABL 2.0 panel for patients with chronic myeloid leukemia.

Precipio, Inc. NEW HAVEN, Conn., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO) today announced that it has implemented a 1-for-20 reverse ...Inside Precipio, Inc.'s 10-K Annual Report: Revenue - Product Highlight. To meet our current and future obligations we have taken the following steps to capitalize the business and successfully achieve our business plan: On April 2, 2021, we entered into a sales agreement with A.G.P./Alliance Global Partners ("AGP"), pursuant to which we may offer and sell our common stock, par value $0.01 per ...

Item 1.01. Entry into a Material Definitive Agreement. Merger Agreement . On October 12, 2016, Transgenomic, Inc. (“Transgenomic”), New Haven Labs Inc., a wholly owned subsidiary of Transgenomic (“Merger Sub” and, together with Transgenomic, the “Transgenomic Parties”), and Precipio Diagnostics, LLC (“Precipio”) entered into an …ITEM 1 (a) NAME OF ISSUER: Precipio, Inc. ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 4 Science Park, New Haven, CT 06511 . ITEM 2 (a) NAME OF PERSON FILING: Leviston Resources LLC . ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 708 Third Avenue, 6 th …Co-Founder & COO at Precipio, Inc. (NASDAQ: PRPO) New Haven, CT. Connect Mark Rimer New York, NY. Connect Ayman Mohamad Chief Technology Officer at Precipio, Inc ...Mogo Inc. (NASDAQ:MOGO) Q3 2023 Earnings Call Transcript November 9, 2023 Mogo Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. Operator: Good afternoon, ladies and gentlemen. And welcome to the Mogo Third Quarter 2023 Earnings Conference Call [Operator Instructions]. This call is being recorded on …Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in cytogenetics, and slow TAT’s for molecular testing. HemeScreen, and IV-Cell were developed in our lab to solve common industry ...

Proprietary Technologies. Precipio has developed several cutting-edge technologies to provide unparalleled diagnostic accuracy. These technologies help address issues from low cellularity, false negatives in cytogenetics, and slow TAT’s for molecular testing. HemeScreen, and IV-Cell were developed in our lab to solve common industry ...

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company’s technologies include HemeScreen and IV-Cell.

d423153dex101.htm. EX-10.1. This Debt Settlement Agreement ( ) is effective as of October 31, 2017 and is executed and entered into by and among Precipio, Inc. (the ), the creditors of the Company now or hereafter signatory hereto (the ) and Collateral Services LLC. , each Vendor has provided certain goods and/or services (the ) to the Company;23 Jun 2023 ... Precipio Inc. and an academic healthcare institution will jointly develop a panel for glioblastoma brain cancer based on HemeScreen.PRECIPIO, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State of Incorporation) 001-36439 (Commission File Number) 91-1789357 (I.R.S. Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)NEW HAVEN, Conn., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces the launch of …C/O PRECIPIO, INC. 4 SCIENCE PARK (Street) NEW HAVEN: CT: 06511 (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol Precipio, Inc. [ PRPO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X: Director: 10% Owner: X: Officer (give title below)

Includes base and annual incentives. $69 k. $75 k. $81 k. $70,565. $81,784. $76,035. These charts show the average base salary (core compensation), as well as the average total cash compensation for the job of Electrical Engineer I in Orlando, FL. The base salary for Electrical Engineer I ranges from $69,569 to $79,708 with the average base ...Balance Sheet. Stock analysis for Precipio Inc (PRPO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and …Precipio, Inc. (NASDAQ:PRPO) posted its earnings results on Thursday, August, 23rd. The biotechnology company reported ($3.00) earnings per share (EPS) for the quarter, missing the consensus estimate of $38.60 by $41.60. The biotechnology company had revenue of $0.82 million for the quarter.[relinking] Home Product Place Promotion Price Precipio, Inc. (PRPO) reported a revenue of $3.5 million in the first quarter of 2022. The company's net income for the same period was $-3.2 million. In terms of product, Precipio offers diagnostic products and services for oncology and COVID-19 testing. As of 2022, Precipio's stock price is $3.45 per share. …Precipio, Inc. 4 Science Park . New Haven, Connecticut 06511 (203) 787-7888 (Name, address, including zip code and telephone number, including area code, of agent for service) Copies to: Thomas A. Rose . Sichenzia Ross Ference LLP. 1185 Avenue of the Americas, 37th Floor. New York, NY 10036Precipio, Inc. Aug 2022 - Present 1 year 4 months Precipio’s Products Division, develops, produces and sells proprietary diagnostic products to laboratories.

Appointment of New Directors . On September 26, 2017, Precipio, Inc. (the “Company”) elected each of Douglas Fisher, M.D. and Jeffrey Cossman, M.D. to the Board of Directors of the Company (the “Board”) to fill existing vacancies on the Board, each to serve until the Company’s 2018 annual meeting of stockholders or his earlier resignation, retirement or …Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScree...

Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. The Company's technologies include HemeScreen and IV-Cell. IV-Cell is a cell culture media …HemeScreen ® Reagents Product Information. HemeScreen is a Research Use Only (RUO) proprietary mutation detection technology that is rapid, cost-effective, and easy-to-use. HemeScreen reagents can be run on most RT-PCR instruments and leverage efficient HRM (High Resolution Melt) technology to identify gene mutations and other variants at low …PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1789357 (IRS Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)Hayward Pool Products Inc has been a leader in the swimming pool industry for over 90 years. Founded in 1925, Hayward has been committed to providing innovative and high-quality products for residential and commercial pools.Precipio expects the project to be completed by the end of Q1 2020. On December 17th, Precipio announced the receipt of their first commercial order for IV-Cell from Northwell Health. Precipio estimates generating considerable six-figures in annual revenues to the company as the first midsize customer to adopt IV-Cell.Precipio Corporate Deck. Who is Precipio? We are creating clinically impactful, cost-effective cancer diagnostic technologies to eliminate laboratory diagnostic errors. Discover how we excel as a blood cancer laboratory, dedicated to specialized diagnostic services for physicians and patients. Learn more at Precipio.Aug 16, 2022 · About Precipio. Precipio Inc. is a healthcare company focused on cancer diagnostics. The Company’s mission is to address the pervasive problem of cancer misdiagnosis by developing products to ... We’re currently recruiting for the following positions: • Product Support Specialist, Products Division, (Hybrid/Remote) • Business Development Manager, Products Division, (Remote) • Cytogenetics FISH Technologist, Clinical Diagnostics Division (New Haven, CT) • Molecular Technologist I, Clinical Diagnostics Division (Omaha, NE)

On March 26, 2020, Precipio. Inc. (“we” or the “Company”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”) with Lincoln Park Capital Fund, LLC (“Lincoln Park”) pursuant to which Lincoln Park has agreed to purchase from us, from time to time, up to …

Nov 16, 2023 · NEW HAVEN, Conn., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2023 corporate update call on November 20 th, 2023 at ...

NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce its 11 th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1 st, 2022 at the ...Private Placement . On the Closing Date and in connection with the Merger, New Precipio issued 107,056 shares of New Preferred Stock (the “Private Placement Shares”) at a price of $3.736329 per share to certain investors in exchange for $400,000 pursuant to a Securities Purchase Agreement (the “Private Placement Purchase Agreement”) between New …Aug 1, 2023 · Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. It develops and sells diagnostic products, reagents and services that improve the accuracy and efficiency of diagnostics, and lead to fewer misdiagnoses. Nov 20, 2023 · Precipio, Inc. (NASDAQ:NASDAQ:PRPO) Q3 2023 Earnings Conference Call November 20, 2023 5:00 PM ETCompany ParticipantsIlan Danieli - Chief Executive... PRECIPIO, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-36439 (Commission File Number) 91-1789357 (IRS Employer Identification No.) 4 Science Park, New Haven, CT 06511 (Address of principal executive offices) (Zip Code)Precipio, Inc. operates as a biotechnology company. The Company offers medicines for oncology, cardiology, neurology, and inherited diseases. Precipio also provides …The average Software Engineering Director salary in San Diego, CA is $225,982 as of October 25, 2023, but the range typically falls between $206,046 and $253,820. Salary ranges can vary widely depending on many important factors, including education, certifications, additional skills, the number of years you have spent in your profession.Based on current volume within CHCWM’s laboratory, and taking into consideration the future add-on HemeScreen proprietary assays, Precipio anticipates potential revenues starting at $75,000 ...Precipio Inc. First, up the list, Precipio is red hot in the stock market now. The company is launching its rapid COVID-19 antibody test for sale on the world’s biggest e-commerce Amazon ...Precipio, Inc. Street Address 1 Street Address 2; 4 Science Park: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; New Haven: CONNECTICUT: 06511 (203) 787-7888: 3. Related Persons. Last Name First Name Middle Name; Danieli: Ilan: Street Address 1 Street Address 2; c/o Precipio, Inc. 4 Science …

Skillsoft’s online learning platform helps organizations to identify and measure skill proficiencies to ensure their workforce stays relevant. The platform makes skilling personalized and accessible, offering a blend of self-paced online courses, hands-on practice, virtual live online classes, and coaching to close skill gaps. Jun 14, 2023 · Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality ... Conference Call to be held on Monday, April 3rd, 2023 at 5:00 PM ETNEW HAVEN, Conn., March 28, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be ...Exhibit 99.1 . Precipio Announces Q2-2023 Shareholder Update Call. Conference Call to be held on August 17, 2023 at 5:00 PM EST. NEW HAVEN, CT, (August 10 th, 2023) - Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q2-2023 corporate update call on August 17 th at 5:00 PM ET. The call will include …Instagram:https://instagram. economy linux hostingssys share24 tesla model 3what are the best reits to invest in Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.Flow Cytometry Lead Technologist at Precipio, Inc West Haven, Connecticut, United States. 196 followers 195 connections See your mutual connections. View mutual connections with Kayley ... low cost futures brokerswhere to buy curaleaf stock The average Civil Engineer I salary in Seattle, WA is $82,976 as of October 25, 2023, but the range typically falls between $75,790 and $91,047. Salary ranges can vary widely depending on many important factors, including education, certifications, additional skills, the number of years you have spent in your profession.Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement. NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company ... unlock mortgage reviews Jun 8, 2023 · Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement. NEW HAVEN, Conn., June 08, 2023 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company ... On September 4, 2020, Precipio, Inc (the "Company") announced that management will host shareholder call to discuss the company's COVID-19 progress and future plans. The call will take place on Wednesday, September 9th at 5:00PM EST. Shareholders may submit their questions up until 5PM on September 7, 2020 by email to …Find the latest Precipio, Inc. (PRPO) stock quote, history, news and other vital information to help you with your stock trading and investing.